Skip to content

Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: Effect on Left Ventricular Function

Short Term Modulation of Circulating Free Fatty Acids in Heart Failure Patients With Type 2 Diabetes: Effect on Myocardial Lipid Content, Left Ventricular Function and Exercise Capacity

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01192373
Acronym
Metamod3
Enrollment
18
Registered
2010-09-01
Start date
2010-09-30
Completion date
2012-03-31
Last updated
2013-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Heart Failure

Brief summary

The investigators wish to investigate the the short term effect of low circulating free fatty acids in congestive heart failure patients with type 2 diabetes. Hypothesis: Low levels of circulating free fatty acids decrease myocardial and peripheral muscle lipid content, improves cardiac performance and exercise capacity.

Interventions

OTHERMetabolic substrate modulation

for high circulation free fatty acids: Heparin (250IE/hour) + intralipid (20%, 62 ml/hour).

OTHERmetabolic substrate modulation

low circulating free acids: hyperinsulinaemic euglycemic clamp (0,8 mUkg/min) with venous blood glucose at 4,5-6,5 mM.

Sponsors

Danish Heart Foundation
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ejection fraction at or lower than 45% * type 2 diabetes

Exclusion criteria

* known s-creatinine \>220mM * known S-alanine aminotransferase \>3 times normal upper limit * other disabilitating conditions * pregnancy * insulin treatment

Design outcomes

Primary

MeasureTime frameDescription
Left ventricular function1-6 weeksLeft ventricular systolic function (Ejection fraction, tissue velocity, Strain and strain rate). Left ventricular diastolic funtion (E/A ratio, E/e' ratio, IVRT) Cardiac output. All parameters measured at rest and peak exercise and outcome is difference between low and high ciculating free fatty acids.
intracellular lipid content1-6 weeksMagnetic Resonans proton spectroscopy (septal myocardial intracellular lipid content) Magnetic Resonans proton spectroscopy (Tibialis anterior muscle intracellular lipid content). Outcome is difference between low and high ciculating free fatty acids.
Exercise capacity and oxygen consumption1-6 weeksUsing treadmill and continues oxygen consumption measurement. Outcome is difference between low and high ciculating free fatty acids.

Secondary

MeasureTime frameDescription
Regional left ventricular function1-6 weeksregional speckle tracking during rest and peak exercise. Outcome is difference between low and high ciculating free fatty acids.
6 minutes hall walk test1-6 weeksdistance difference between low and high levels of circulating FFA. Outcome is difference between low and high ciculating free fatty acids.
metabolic and hormonal profile1-6 weeksbloodsamples

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026